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Validation and Regulatory Issues in the Pharmaceutical Industry
MS PhEn604
Instructor: Paul Melamud, PMP

Part 1: About This Course:
Class and Instructor Information:

Term:

Spring 2021

NJIT Course Title:
NJIT Course Number:
Course Day & Time:
Classroom

Validation and Regulatory Issues in the Pharmaceutical Industry

Course Prerequisites:

Graduate Student Standing
NJIT UCID & CANVAS Account (IMPORTANT)
PhEn601 (preferred, but not required)
Technical Writing & Formal Argument skills
(strongly recommended)

Course Instructor:

Paul A. Melamud, PMP

Grader:

TBD

Instructor Contact:

Message via CANVAS (Primary)
E-mail via pam7@njit.edu (Secondary)

PhEn604
Online Section
NJIT CANVAS @ https://canvas.njit.edu/

Instructor’s Office Hours:
Your instructor is an industry professional who often works over 50 miles away from
Newark, NJ, and does not have an office on campus. He therefore does not have inperson office hours. Instead, your teacher can be reached through NJIT’s CANVAS
and e-mail platforms. There are three “rules” the instructor asks:
1)

If you have a general question about the class or a specific question regarding
the lecture or reading materials (i.e. you don’t understand something), or require
clarification about an assignment, please post in the DISCUSSIONS area within
CANVAS. The instructor strongly believes that if you have a question, so does at
least one other person in the class, and this will allow everyone to benefit.

2)

If you have a personal question (e.g. grading other personal issue), please use a
private message through the CANVAS INBOX (CANVAS is preferred vs. e-mail).
This way, the rest of the class will not see the discussion.

Note: you may be contacted by the instructor via one of his e-mail addresses, in which
case you may respond directly, but if you start a new conversation, please do it through
CANVAS or it may not be seen for some time.
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Course Description (from your Instructor):
This class was designed to provide the students with as much of the background, fact,
and interpretation of the pharmaceutical industry’s underlying governmental regulations
as can be possibly fit into a single semester.
That is a lot of material. The Code of Federal Regulations (CFR) is long and can be dull
and confusing, even to a lawyer. Our government is not known for brevity. But as we
will learn there are reasons for how they’re written and we will cover the critical portions
during this course as they relate to the pharmaceutical industry.
We'll try to make the regulations as painless as possible. It is not my goal that you
become able to quote regulations "by the book" – there is plenty of time for that when
you’re working in the industry. It is much more important that you gain an appreciation
for WHY we have and HOW we use the various regulations, guidelines, and standards
that we follow in the pharmaceutical industry.
We will gain this understanding by viewing the entire industry, from drug discovery
through post-marketing. We will highlight most of the major regulatory concepts, and
their reasons for existence. And yes, there are times we will quote regulations, but we
will try to digest together what they are really asking us to do.
This course is focused on the development of a working knowledge of Title 21 of the
CFR and its interpretations and applications within the pharmaceutical and allied
industries. In this pursuit, we shall study the history and role of the FDA, and the
reasons underlying the regulations that now shape the way pharmaceutical companies
do business. Of primary focus shall be the roles of “cGXPs” as we know (and are
required to use) them today.
In addition, we shall discuss the concept of “Validation”, primarily known to the
pharmaceutical industry, but increasingly recognized by others as well – software
developers, for example. As Validation is a primary activity for ensuring safety and
efficacy of a pharmaceutical product, as well as the quality and integrity of the data
supporting these assurances, we shall study this concept in such a manner that the
student should be able to anticipate the requirements and apply sound principles for
validation of any new process, system, equipment, or laboratory method.
Finally – for those of you taking this course as a cross-curriculum breadth requirement,
or have no experience in the industry, I will provide you with enough supplemental
reading and other resources to catch up with the full-time industry professionals that
also take this course. We don't have time to repeat the material of the other PhEn
courses, so I hope you ask lots of questions so everyone can benefit.
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Coursework & Grading Policy:
Please ignore the CANVAS “overall grade” calculation – sometimes it is correct,
sometimes it is not, and it is not something the Professor can control. You may track
your grade manually as follows:






20% of your grade based on the homework and “in class” assignments
20% of your grade based on the quizzes
20% of your grade based on each of the Midterm Exam & Final Exam
5% of your grade based on Class Participation (Discussions on CANVAS, et al)
15% of your grade based on a validation project, if issued by the professor. Otherwise, this will be
distributed evenly over the other grade elements.

You may expect the FINAL GRADE (not the Final Exam grade) to be “curved” utilizing
the class final grade Mean and Standard Deviation. As a general rule of thumb,
consider the Mean + 1 Standard Deviation to be the “B Range”, the Mean - 1 Standard
Deviation = “C Range”, and “A” and “F” grades following suit (remember: there is no “D”
grade in graduate courses).
Please note that this is a general guideline only – for instance, if everyone in the
class achieves 75 or better in the course, then the grades can be expected to be curved
from A-C, not A-F.
Remember – you will get out of this class what you put into it. If you truly put in A-grade
effort, there is little reason to expect you should not achieve an A-grade as a result.
Attendance and Homework Submission Deadline Policies:
As for all graduate courses at NJIT attendance is not mandatory, however, it is
strongly recommended. Students are responsible for all material presented in class.
All work is due by the date and time specified, which is most often two weeks or more
after the assignment is issued. This allows us at least one week to discuss any hurdles
or questions that arise. It is therefore encouraged you begin the assignments within a
few days of their being issued.
Please upload all assignments on CANVAS using a MS Word .DOC or a .DOCX file.
This will allow the professor or grader to easily comment on assignments. A PDF file
will work but is not preferred, as the instructor cannot readily make comments on your
assignment.
Extensions on assignment deadlines are not typically provided. In the event you
have an extenuating circumstance, you are required to notify the instructor as soon as
possible with the reason and your expected submission date. Although all due
considerations shall be made, the instructor reserves the right to deny anyone an
extension for any reason. Having “other work due” is not a reasonable excuse for
requesting an extension. And please be respectful – do not expect much leeway if
you e-mail the instructor the night before an assignment when you could have done so
a week or more previously.
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Exam Expectations:
Exams for the online section shall be distributed online. Exams for the classroom
section shall be distributed during a regularly scheduled class period.
Bring whatever resources you wish in order to take the exam. There is to be no
collaboration with other people allowed, however – as noted on the next page, cheating
and plagiarism can result in a zero for the assignment or expulsion from class.
It is expected that the Midterm shall focus primarily on basic concepts and vocabulary,
while the Final shall focus more on interpretations and applications, though both shall
have Case Studies. The Final will focus on the material presented after the Midterm.
“Textbook” & Reference Materials:
The “Good” News:
There is no textbook for this class
The “Bad” News:
There is still a substantial amount of reading for this class
Lecture Notes, articles, and other materials shall be distributed via CANVAS.
Primary references that you should read and be familiar with will be provided as PreReading or Mandatory Reading. It is expected that, by reviewing and understanding
these documents, you will develop a working knowledge of the material to a degree
similar to that of industry professionals. Where possible and within the time constraints
of the class, this shall be supplemented and reinforced with application of the
knowledge by way of “real-life” case studies, discussions, and activities in class.
The instructor also recognizes that not everyone taking this class has experience in the
industry or in this degree program. Therefore, “Catch-Up” material will be provided to fill
in gaps in the foundations of the topics that are not gone over in class (e.g. basics from
PhEn601). The instructor may also assign “Optional” readings, which go into some
topics in greater detail, or bring up other related topics that are not otherwise covered in
class. All students are encouraged to read these at their discretion, especially if they
are considering a career in the allied healthcare industries.
Lecture Notes:
The instructor’s Lecture Notes are most often a distillation or focus on the material
provided as Mandatory Reading in CANVAS. It is expected that the student reads
these materials for a given class PRIOR to the classroom lecture, so the class time can
be spent listening, discussing, and annotating, rather than writing down a lot of notes as
the instructor speaks.
The instructor uses Adobe Acrobat for most of the files, but please note that some are
formatted for the current version of Microsoft Office – if you have an older version of this
software, the Microsoft website offers a free conversion tool.
Please note: the class provides many hyperlinks to active internet sites, including those
maintained by the US government. Sometimes, these links change. If you encounter
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broken references while studying, please try to find the correct link online and share
with the class (CANVAS bulletin board) so the professor can correct them for next time.
If you cannot find the correct link, please ask.

Guidelines on Writing Assignments & Term Papers:
As a graduate student, you should already know how to write an academic paper or
research-based homework assignment. However, if you have any doubts, please refer
to the following link which provides some information:
http://www.gale.cengage.com/free_resources/term_paper/index.htm.
Here is another, which focuses on the “MLA Format” – this shall show you one “proper
way” to cite your resources and to format your papers: https://style.mla.org/.
If you have ANY doubts or questions about what constitutes a “proper” assignment,
please consult with the NJIT library in advance of your assignment deadlines – they
have wonderful and numerous literary resources and personnel to help you.
Reminders of Relevant NJIT Academic Policies & Programs:
 http://catalog.njit.edu/graduate/frontmatter/academicpolicy.php - Academic
policies and procedures
 http://www.njit.edu/education/pdf/academic-integrity-code.pdf - NJIT Honor
Code, including the school’s “no tolerance” position on plagiarism
 https://ist.njit.edu/support/contactus.php - Help for using CANVAS
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Part 2: General Course Outline:
Note: lecture units will be issued through CANVAS 1-2 per week (some units are larger than
others).

Lecture Unit #
Lecture 1
Regulatory History
Lecture 2
R&D: Pre-Clinical
Lecture 3
R&D: Clinical &
Approval
Lecture 4
Manufacturing

Lecture 5
Validation Program
Lecture 6
C&Q
Lecture 7
Facilities/Utilities
Lecture 8
(if time allows)
March 8

Anticipated Topic(s)































Introduction
International Regulatory Framework
USC, CFR, USDHHS, & FDA
FDA Regulatory History
Definitions of FDA Regulated Products
R&D, GLPs, & Non-Clinical Trials
INDs (CDER/CBER), IDE (CDRH) & DMFs/VMFs
GCPs & Clinical Trials
Informed Consent & IRBs
NDA (CDER), BLA (CBER), NADA (CVM), & PMN (510(k))/PMA
(CDRH)
APRs & Pharmacovigilance
Adulteration & Misbranding
USP-NF
FDA GMPs
ICH Q7: GMPs for BPCs & APIs
SUPAC & the PAS, CBE, or Annual Reportable
VMPs & PVPs
Protocols and Reports
Discrepancies & Deviations
GDPs
RS, FS, DS, and the Traceability Matrix
GEP: DQ, Commissioning, FAT, & SAT
Equipment Qualification: IQ, OQ, PQ
Handover & Post-Handover Programs
Facility Design & Validation (Overview)
HVAC & ISO 14644 Acceptance Criteria
Utilities Design & Validation (Overview)
USP PW, WFI & Compressed Air Acceptance Criteria
This lecture is a “float” that may be presented in either half of the class,
depending on available time and class progression.
See next page for lecture details

MID-TERM EXAMINATION WEEK begins (Lectures 1-7)
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Lecture & Week
Given (approx)
Lecture 8
Process Validation
Lecture 9
Environment
Lecture 10
CSV
Lecture 11
Examples Applying
Validation Statistics
Lecture 12
AMV & Micro

Lecture 13
Modern Initiatives:
Inspections & QBD
Lecture 14
Packaging
Serialization
May 7

Anticipated Topic(s)















SISPQ
Process Validation & FDA’s new Guidance Document
ICH Q8A Overview
Air Waste & CFCs – CAA, Montreal Protocol
Water & Water Waste – CWA, SWDA, NPDES
Solids & Solid Waste – RCRA, DOT, RMW
Emergencies & CRTK – CERCLA, SARA, EPCRA
BMS, MRP/ERP, CDS, LIMS
CSV and 21 CFR 11
Spreadsheets
Related SOPs
Cleaning Validation & MACO
Environmental Mapping Studies & MKT
Continuous Sampling: AQLs & ANSI Z1.4














Analytical Testing “Figures of Merit”
System Suitability
Analytical & Bio-analytical Method Validation
Microbiology & Sterility Testing
Stability Testing
“GMPs for the 21st Century”
ICH Q8-Q10: QbD, QbR, and Quality Risk Management
The “QS Approach” & PAIs
Other Inspections and Audits
International Overview of Serialization & Product Tracking
US DSCSA
GS1 & HDA

FINAL EXAMINATION WEEK begins (Lectures 8-14)

Supplemental Lectures – the professor has prepared additional short presentations
that cover other related topics; these shall be presented as class time and interest
allow. Any/all supplements are fair game for exams and homework.

